These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27798919)

  • 1. Clinical Significance of 18F-FDG-PET in Invasive Lobular Carcinoma.
    Fujii T; Yajima R; Kurozumi S; Higuchi T; Obayashi S; Tokiniwa H; Nagaoka R; Takata D; Horiguchi J; Kuwano H
    Anticancer Res; 2016 Oct; 36(10):5481-5485. PubMed ID: 27798919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
    Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
    World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
    Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
    J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers.
    Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C
    J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
    Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
    Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological Features of Cases with Primary Breast Cancer not Identified by 18F-FDG-PET.
    Fujii T; Yajima R; Tsuboi M; Higuchi T; Obayashi S; Tokiniwa H; Nagaoka R; Takata D; Horiguchi J; Kuwano H
    Anticancer Res; 2016 Jun; 36(6):3019-22. PubMed ID: 27272820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of Breast MRI and (18)F-FDG PET/CT for the Preoperative Staging of Invasive Lobular Carcinoma versus Ductal Carcinoma.
    Jung NY; Kim SH; Kim SH; Seo YY; Oh JK; Choi HS; You WJ
    J Breast Cancer; 2015 Mar; 18(1):63-72. PubMed ID: 25834613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
    Ueda S; Tsuda H; Asakawa H; Shigekawa T; Fukatsu K; Kondo N; Yamamoto M; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
    Jpn J Clin Oncol; 2008 Apr; 38(4):250-8. PubMed ID: 18407934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective Pilot Study of
    Covington MF; Hoffman JM; Morton KA; Buckway B; Boucher KM; Rosenthal RE; Porretta JM; Brownson KE; Matsen CB; Vaklavas C; Ward JH; Wei M; Buys SS; Chittoria N; Yakish ED; Archibald ZG; Burrell LD; Butterfield RI; Yap JT
    AJR Am J Roentgenol; 2023 Aug; 221(2):228-239. PubMed ID: 36919879
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial volume corrected 18F-FDG PET mean standardized uptake value correlates with prognostic factors in breast cancer.
    Gallivanone F; Canevari C; Sassi I; Zuber V; Marassi A; Gianolli L; Picchio M; Messa C; Gilardi MC; Castiglioni I
    Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):424-39. PubMed ID: 24732679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.
    Ahn SG; Park JT; Lee HM; Lee HW; Jeon TJ; Han K; Lee SA; Dong SM; Ryu YH; Son EJ; Jeong J
    Breast Cancer Res; 2014; 16(6):502. PubMed ID: 25551703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
    Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
    Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-Head Evaluation of
    Ulaner GA; Jhaveri K; Chandarlapaty S; Hatzoglou V; Riedl CC; Lewis JS; Mauguen A
    J Nucl Med; 2021 Mar; 62(3):326-331. PubMed ID: 32680923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between 18F-fluorodeoxyglucose Positron Emission Tomography/computed Tomography and Clinicopathological Features in Invasive Ductal Carcinoma of the Breast.
    Ito M; Shien T; Kaji M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
    Acta Med Okayama; 2015; 69(6):333-8. PubMed ID: 26690243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging and (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer: Correlation of the apparent diffusion coefficient and maximum standardized uptake values with prognostic factors.
    Karan B; Pourbagher A; Torun N
    J Magn Reson Imaging; 2016 Jun; 43(6):1434-44. PubMed ID: 26663655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between FDG Uptake and Neutrophil/Lymphocyte Ratio in Patients with Invasive Ductal Breast Cancer.
    Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Shirabe K
    Anticancer Res; 2018 Aug; 38(8):4927-4931. PubMed ID: 30061271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of 18F-fluorodeoxyglucose uptake with histopathological prognostic factors in breast carcinoma.
    Ekmekcioglu O; Aliyev A; Yilmaz S; Arslan E; Kaya R; Kocael P; Erkan ME; Halac M; Sonmezoglu K
    Nucl Med Commun; 2013 Nov; 34(11):1055-67. PubMed ID: 24025919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E
    Clin Radiol; 2008 Nov; 63(11):1213-27. PubMed ID: 18929039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological Features of Ductal Carcinoma
    Fujii T; Yanai K; Tokuda S; Nakazawa Y; Kurozumi S; Obayashi S; Yajima R; Hirakata T; Kuwano H
    Anticancer Res; 2017 Sep; 37(9):5053-5056. PubMed ID: 28870933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.